Liquid biopsy could better predict immunotherapy response in lung cancer patients than tumor biopsy

By | June 3, 2022
Mount Sinai researchers have validated for the first time that a simple blood test called a liquid biopsy could be a better predictor of whether cancer immunotherapy will be successful for a patient with lung cancer than an invasive tumor biopsy procedure.